Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sarcolemmal ATP-sensitive potassium (sarcKATP) channels are metabolic sensors located on the plasma membrane of cardiac, skeletal, and smooth muscle cells (Foster and Coetzee, 2016, PMID: 26854689). They are hetero-octameric complexes typically composed of four pore-forming inward-rectifier potassium channel subunits (Kir6.1 or Kir6.2) and four regulatory sulfonylurea receptor subunits (SUR1, SUR2A, or SUR2B) (Hibino et al., 2010, PMID: 20621961). These channels couple the intracellular metabolic state, specifically the ATP/ADP ratio, to the cell's electrical activity by opening when ATP levels drop. Channel opening leads to potassium efflux and membrane hyperpolarization, which in cardiac cells shortens the action potential duration to reduce energy consumption and calcium overload during ischemia (Zingman et al., 2002, PMID: 11834834). In vascular smooth muscle, sarcKATP channels play a vital role in regulating vascular tone and systemic blood pressure (Quayle et al., 1997, PMID: 9236240). Pharmacological openers of these channels, such as nicorandil and pinacidil, are used clinically for their vasodilatory and cardioprotective effects (Jahangir and Terzic, 2005, PMID: 15734335). Conversely, sulfonylureas like glibenclamide act as blockers and are primarily used to treat diabetes by targeting the pancreatic isoform, though they can affect sarcolemmal channels. Mutations in the genes encoding these subunits are linked to disorders such as Cantu syndrome and certain forms of hyperinsulinism (Harakalova et al., 2012, PMID: 22703870).
Potassium channel openers (KCOs) bind to the regulatory sulfonylurea receptor (SUR) subunits of the sarcolemmal ATP-sensitive potassium channel, promoting the open state of the pore-forming Kir6.x subunits. This leads to an efflux of potassium ions and subsequent membrane hyperpolarization. In cardiac tissue, this action shortens the action potential duration, reducing calcium influx and preserving cellular energy during ischemic stress. In vascular smooth muscle, hyperpolarization leads to the closure of voltage-gated calcium channels, resulting in vasodilation and decreased peripheral resistance.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sarcolemmal ATP-sensitive potassium channel (sarcKATP) (sarcKATP).